J&J has launched its Shockwave C2 Aero Coronary IVL Catheter globally, marking an advancement in the treatment of calcified ...

The Shockwave C2 Aero is designed to streamline treatment strategies by improving flexibility for physicians.

In a deal that might as well be termed a heart-to-heart, Shockwave Medical has made a bid to combine Neovasc’s cardiac device business with its own. Shockwave has offered up $27.25 in upfront cash for ...

FREDERICK, MD, UNITED STATES, February 3, 2026 /EINPresswire.com/ — Limitless Evolution announces the launch of the ReGen Medical RCT Shockwave Device, an advanced ...

Shockwave will purchase outstanding Neovasc shares for $27.25 each, valuing the company at around $100 million, according to a Jan. 17 news release from Shockwave. Neovasc specializes in the treatment ...

(Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical in a deal valued at $13.1 billion including debt, as it builds its cardiac-health-centric medical devices business to help drive ...

As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...